IFR US ECM Pricings
Agomab Therapeutics (Belgium, biotech) – $200m IPO. 12.5m shares (Primary) at $16.00 versus $15-$17 marketing. JPM, MS, LEER, VSK. Nasdaq "AGMB".
Cambridge Acquisition (US, SPAC) – $200m IPO. 20m units (Primary) at $10.00. BTIG. Nasdaq. “CAQU”. Each unit comprises one share and one-third warrant. Brent Michael Cox. Undefined. 24 months. 100% in trust.
Once Upon a Farm (US, consumer goods) – $198m IPO. 11m shares (Primary, Secondary) at $18.00 versus $17-$19 marketing. GS, JPM, BOFA, WBLR. NYSE "OFRM". Public benefit corporation.
Satellos Bioscience (Canada, biotech) – $51m ABB. 5m shares (Primary) at $10.10 fixed price versus C$16.15 last sale/reference price. LEER, GUGG, OPCO. Nasdaq uplisting from TSX.
SPACSphere Acquisition (US, SPAC) – $150m IPO. 15m units. (Primary) at $10.00. DBORAL. Nasdaq “SSACU”. Each unit comprises one share, one-half warrant and one right. Bala Padmakumar. Digital assets. 18 months. 100% in trust.
SpyGlass Pharma (US, biotech) – $150m IPO. 9.4m shares (Primary) at $16.00 versus $15-$17 marketing. JEFF, LEER, CITI, STFL. Nasdaq "SGP"
Postponed
Liftoff Mobile (US, adtech) – $762m IPO. 25.4m shares (Primary) marketed at $26-$30. GS, JEFF, MS. Nasdaq “LFTO”. Scheduled to price 2/5. Blackstone Group and General Atlantic Partners were among the existing shareholders.